Insulet Corporation Files Notice of Data Breach That Leaked Consumers’ Protected Health Information | Console and Associates, P.C.

On January 5, 2023, Insulet Corporation filed notice of a data breach with the Attorney General of California after learning that confidential information belonging to certain consumers was compromised. Based on the company’s official filing, the incident resulted in an unauthorized party gaining access to consumers’ protected health information (“PHI”). After confirming that consumer data was leaked, Insulet began sending out data breach notification letters to all individuals who were impacted by the recent data security incident.

If you are an Insulet customer, the company’s recent data breach may mean that hackers and other cybercriminals now have your personal health information in their possession. As we’ve discussed in previous postsHealthcare data breaches are increasingly common, as hackers have learned how to generate astronomical profits by using the information they acquire in these attacks to commit a variety of frauds. However, as a data breach victim, you have certain rights, including the right to file a data breach lawsuit against any company that negligently leaked your information. While the investigation into the Insulet breach is still ongoing, data breach lawyers can advise affected consumers about their rights and help them determine the best course of action.

What We Know So Far About the Insulet Corp. Breach

The available information regarding the Insulet Corp. The breach comes from the company’s filing with the Attorney General of California. According to this source, on December 1, 2022, Insulet sent out emails to certain individuals. These emails included a link that directed the user to a verification page on the omnipod.com website. The URL of the webpage where the users were directed contained their protected health information. Subsequently, these URLs were provided to certain “performance and marketing partners” through the use of cookies and other trackers embedded in the omnipod.com website code.

On January 5, 2022, Insulet Corp. sent out data breach letters to all individuals whose information was compromised as a result of the recent data security incident.

More Information About Insulet Corporation

Insulet Corporation is a medical device manufacturer based in Acton, Massachusetts. The company’s flagship product, the Omnipod delivery system, is advertised as the only tubeless automated insulin delivery system approved for individuals with type 1 diabetes, ages 2 and older. Insulet is publicly traded on the NASDAQ, under the ticker symbol “PODD.” Insulet Corp. It employs more than 2,300 people and generates approximately $1.1 billion in annual revenue.

Leave a Comment